ArticleMetabolomics : Official journal of the Metabolomic Society2016

Presence of arachidonoyl-carnitine is associated with adverse cardiometabolic responses in hypertensive patients treated with atenolol.

Liming Weng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.